Formononetin ameliorates muscle atrophy by regulating myostatin‐mediated PI3K/Akt/FoxO3a pathway and satellite cell function in chronic kidney disease

Muscle atrophy is a common complication in chronic kidney disease (CKD). Inflammation and myostatin play important roles in CKD muscle atrophy. Formononetin (FMN), which is a major bioactive isoflavone compound in Astragalus membranaceus, exerts anti‐inflammatory effects and the promotion of myogeni...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Cell Mol Med
Egile Nagusiak: Liu, Lingyu, Hu, Rong, You, Haiyan, Li, Jingjing, Liu, Yangyang, Li, Qiang, Wu, Xiaohui, Huang, Jiawen, Cai, Xiangsheng, Wang, Mingqing, Wei, Lianbo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2021
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7875933/
https://ncbi.nlm.nih.gov/pubmed/33405354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.16238
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak